Drug Patents owned by Marius Pharms Llc

1. List of Kyzatrex drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10576089 MARIUS PHARMS LLC Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols
Dec, 2030

(7 years from now)

US10576090 MARIUS PHARMS LLC Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols
Dec, 2030

(7 years from now)

Do you want to check out KYZATREX patents from before 2022?
Exclusivity Exclusivity Expiration
New Product (NP) Jul 27, 2025

Drugs and Companies using TESTOSTERONE UNDECANOATE ingredient

Market Authorisation Date: 27 July, 2022

Treatment: Method of treating testosterone deficiency

Dosage: CAPSULE;ORAL

More Information on Dosage

KYZATREX family patents

12

United States

3

European Union

2

Spain

2

Japan

1

New Zealand

1

Poland

1

China

1

Hong Kong

1

Canada

1

Portugal

1

Taiwan

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in